Even the best stock pickers will make plenty of bad investments. Anyone who held Winning Health Technology Group Co., Ltd. (SZSE:300253) over the last year knows what a loser feels like. The share price is down a hefty 57% in that time. Even if you look out three years, the returns are still disappointing, with the share price down49% in that time. Shareholders have had an even rougher run lately, with the share price down 30% in the last 90 days.
With the stock having lost 4.0% in the past week, it's worth taking a look at business performance and seeing if there's any red flags.
View our latest analysis for Winning Health Technology Group
There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.
Unfortunately Winning Health Technology Group reported an EPS drop of 37% for the last year. The share price decline of 57% is actually more than the EPS drop. So it seems the market was too confident about the business, a year ago.
The image below shows how EPS has tracked over time (if you click on the image you can see greater detail).
SZSE:300253 Earnings Per Share Growth September 26th 2022
This free interactive report on Winning Health Technology Group's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.
A Different Perspective
We regret to report that Winning Health Technology Group shareholders are down 57% for the year (even including dividends). Unfortunately, that's worse than the broader market decline of 17%. However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. Longer term investors wouldn't be so upset, since they would have made 1.3%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For example, we've discovered 2 warning signs for Winning Health Technology Group that you should be aware of before investing here.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on CN exchanges.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
即使是最好的選股者也會做出大量糟糕的投資。任何持有贏利健康科技集團有限公司。(SZSE:300253)在過去的一年裏,我知道失敗者是什麼感覺。在此期間,該公司股價大幅下跌了57%。即使你放眼三年,回報仍然令人失望,在此期間股價下跌了49%。股東們最近經歷了更艱難的時期,股價在過去90天裏下跌了30%。
鑑於該公司股價在過去一週下跌了4.0%,我們有必要看看公司的業績,看看是否有任何危險信號。
查看我們贏得健康科技組的最新分析
不可否認,市場有時是有效的,但價格並不總是反映潛在的商業表現。一種不完美但簡單的方法來考慮市場對一家公司的看法是如何改變的,那就是將每股收益(EPS)的變化與股價走勢進行比較。
不幸的是,Winning Health Technology Group報告去年每股收益下降了37%。股價57%的跌幅實際上比每股收益的跌幅還要大。因此,一年前,市場似乎對這項業務過於自信。
下圖顯示了EPS是如何隨着時間的推移進行跟蹤的(如果您點擊該圖像,您可以看到更多詳細信息)。
深交所:2022年9月26日每股收益增長300253
這免費如果你想進一步調查健康科技集團的股票,那麼關於贏得健康科技集團的收益、收入和現金流的互動報告是一個很好的起點。
不同的視角
我們遺憾地報告,贏得健康科技集團的股東今年以來下降了57%(甚至包括股息)。不幸的是,這比大盤17%的跌幅還要糟糕。然而,這可能只是因為股價受到了更廣泛的市場緊張情緒的影響。也許有必要關注基本面,以防出現良機。較長期的投資者不會如此沮喪,因為他們在五年內每年會獲得1.3%的收益。如果基本面數據繼續顯示長期可持續增長,當前的拋售可能是一個值得考慮的機會。雖然值得考慮市場狀況對股價可能產生的不同影響,但還有其他更重要的因素。例如,我們發現健康科技組獲獎的2個警示標誌在這裏投資之前你應該意識到這一點。
當然了,如果你把目光投向別處,你可能會發現這是一筆很棒的投資。所以讓我們來看看這個免費我們預計收益將會增長的公司名單。
請注意,本文引用的市場回報反映了目前在CN交易所交易的股票的市場加權平均回報。
對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。